{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:14:31Z","timestamp":1762431271398},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To elucidate the impact of a hepatitis B (HB) vaccination program on the prevalence of HB surface antigen (HBsAg) and HB envelope antigen (HBeAg) as well as the success rate of HBeAg clearance among parturients, we collected data on parturients who gave birth between 2000 and 2010, and recorded the HB status postpartum of those with positive HBeAg before birth. A total of 8696 parturients were enrolled, of whom 113 with prenatal positive HBeAg were invited back. The prevalence of HBsAg decreased over the study period, particularly in the vaccinated cohort, while there was no change in the prevalence of HBeAg. Foreign parturients had a higher HBeAg-positive rate and delayed HBeAg clearance, and those with a higher body mass index (&gt;24\u2009kg\/m<jats:sup>2<\/jats:sup>) had earlier HBeAg clearance (51.9% vs. 23.9%, p\u2009=\u20090.005). Only 30% of the subjects who were positive for HBeAg before birth became negative 5 years after delivery. In conclusion, the downward trend in HB infection with more significance among vaccinated parturients reflects effective prevention and the impact of universal HB immunization. Nonetheless, aggressive follow-up is necessary for parturients who are persistently positive for HBeAg postpartum, as well as developing different public health policies for foreign parturients from endemic areas.<\/jats:p>","DOI":"10.1038\/s41598-017-01234-0","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T16:06:45Z","timestamp":1492704405000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area"],"prefix":"10.1038","volume":"7","author":[{"given":"Chen-Hsuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Te-Yao","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Tsai","family":"Kung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan-Chao","family":"ChangChien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"key":"1234_CR1","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1046\/j.1440-1746.2000.0150121356.x","volume":"15","author":"I Merican","year":"2000","unstructured":"Merican, I. et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol \n                           15, 1356\u20131361, doi:10.1046\/j.1440-1746.2000.0150121356.x (2000).","journal-title":"J Gastroenterol Hepatol"},{"key":"1234_CR2","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/ijc.22045","volume":"119","author":"SN Lu","year":"2006","unstructured":"Lu, S. N. et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer \n                           119, 1946\u20131952, doi:10.1002\/ijc.22045 (2006).","journal-title":"Int J Cancer"},{"key":"1234_CR3","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1086\/651231","volume":"201","author":"CW Fwu","year":"2010","unstructured":"Fwu, C. W. et al. Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan. J Infect Dis \n                           201, 1016\u20131023, doi:10.1086\/651231 (2010).","journal-title":"J Infect Dis"},{"key":"1234_CR4","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/1097-0142(19891201)64:11<2377::AID-CNCR2820641130>3.0.CO;2-8","volume":"64","author":"MH Chang","year":"1989","unstructured":"Chang, M. H., Chen, D. S., Hsu, H. C., Hsu, H. Y. & Lee, C. Y. Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer \n                           64, 2377\u20132380, doi:10.1002\/(ISSN)1097-0142 (1989).","journal-title":"Cancer"},{"key":"1234_CR5","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1001\/jama.1987.03390190075023","volume":"257","author":"DS Chen","year":"1987","unstructured":"Chen, D. S. et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. Jama \n                           257, 2597\u20132603, doi:10.1001\/jama.1987.03390190075023 (1987).","journal-title":"Jama"},{"issue":"Suppl 1","key":"1234_CR6","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/S0264-410X(99)00460-0","volume":"18","author":"K Huang","year":"2000","unstructured":"Huang, K. & Lin, S. Nationwide vaccination: a success story in Taiwan. Vaccine \n                           18(Suppl 1), S35\u201338, doi:10.1016\/S0264-410X(99)00460-0 (2000).","journal-title":"Vaccine"},{"key":"1234_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/hep.23348","volume":"51","author":"YC Chen","year":"2010","unstructured":"Chen, Y. C., Chu, C. M. & Liaw, Y. F. Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology \n                           51, 435\u2013444, doi:10.1002\/hep.23348 (2010).","journal-title":"Hepatology"},{"key":"1234_CR8","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","volume":"35","author":"YS Hsu","year":"2002","unstructured":"Hsu, Y. S. et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology \n                           35, 1522\u20131527, doi:10.1053\/jhep.2002.33638 (2002).","journal-title":"Hepatology"},{"key":"1234_CR9","doi-asserted-by":"publisher","unstructured":"Geier, A., Gartung, C. & Dietrich, C. G. Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma. N Engl J Med \n                           347, 1721\u20131722, author reply 1721\u20131722, 10.1056\/nejm200211213472119 (2002).","DOI":"10.1056\/nejm200211213472119"},{"key":"1234_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/tropej\/46.2.121","volume":"46","author":"SN Lu","year":"2000","unstructured":"Lu, S. N., Liu, J. H., Wang, J. H. & Lu, C. C. Secular trends of HBeAg prevalence among HBsAg-positive delivery mothers in a hepatitis B endemic area. J Trop Pediatr \n                           46, 121\u2013123, doi:10.1093\/tropej\/46.2.121 (2000).","journal-title":"J Trop Pediatr"},{"key":"1234_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/jmv.10332","volume":"69","author":"HH Lin","year":"2003","unstructured":"Lin, H. H., Kao, J. H., Chang, T. C., Hsu, H. Y. & Chen, D. S. Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. Journal of medical virology \n                           69, 466\u2013470, doi:10.1002\/jmv.10332 (2003).","journal-title":"Journal of medical virology"},{"key":"1234_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1467-842X.2005.tb00751.x","volume":"29","author":"SR Caruana","year":"2005","unstructured":"Caruana, S. R. et al. Knowledge about hepatitis and previous exposure to hepatitis viruses in immigrants and refugees from the Mekong Region. Aust N Z J Public Health \n                           29, 64\u201368, doi:10.1111\/j.1467-842X.2005.tb00751.x (2005).","journal-title":"Aust N Z J Public Health"},{"key":"1234_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.socscimed.2005.06.015","volume":"62","author":"MS Wingate","year":"2006","unstructured":"Wingate, M. S. & Alexander, G. R. The healthy migrant theory: variations in pregnancy outcomes among US-born migrants. Soc Sci Med \n                           62, 491\u2013498, doi:10.1016\/j.socscimed.2005.06.015 (2006).","journal-title":"Soc Sci Med"},{"key":"1234_CR14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","volume":"2","author":"RP Beasley","year":"1983","unstructured":"Beasley, R. P. et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet \n                           2, 1099\u20131102, doi:10.1016\/S0140-6736(83)90624-4 (1983).","journal-title":"Lancet"},{"key":"1234_CR15","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1001\/jama.1988.03410150079034","volume":"260","author":"HM Hsu","year":"1988","unstructured":"Hsu, H. M. et al. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers. Jama \n                           260, 2231\u20132235, doi:10.1001\/jama.1988.03410150079034 (1988).","journal-title":"Jama"},{"key":"1234_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1086\/504501","volume":"27","author":"JW Liu","year":"2006","unstructured":"Liu, J. W. et al. Epidemiologic study and containment of a nosocomial outbreak of severe acute respiratory syndrome in a medical center in Kaohsiung, Taiwan. Infect Control Hosp Epidemiol \n                           27, 466\u2013472, doi:10.1086\/504501 (2006).","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1234_CR17","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"JJ Ott","year":"2012","unstructured":"Ott, J. J., Stevens, G. A., Groeger, J. & Wiersma, S. T. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine \n                           30, 2212\u20132219, doi:10.1016\/j.vaccine.2011.12.116 (2012).","journal-title":"Vaccine"},{"key":"1234_CR18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.bpg.2008.11.008","volume":"22","author":"K Van Herck","year":"2008","unstructured":"Van Herck, K., Vorsters, A. & Van Damme, P. Prevention of viral hepatitis (B and C) reassessed. Best Pract Res Clin Gastroenterol \n                           22, 1009\u20131029, doi:10.1016\/j.bpg.2008.11.008 (2008).","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1234_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1440-1746.1997.tb00364.x","volume":"12","author":"TI Huo","year":"1997","unstructured":"Huo, T. I. et al. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol \n                           12, 747\u2013751, doi:10.1111\/j.1440-1746.1997.tb00364.x (1997).","journal-title":"J Gastroenterol Hepatol"},{"key":"1234_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2334-12-131","volume":"12","author":"JJ Ott","year":"2012","unstructured":"Ott, J. J., Stevens, G. A. & Wiersma, S. T. The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions. BMC Infect Dis \n                           12, 131, doi:10.1186\/1471-2334-12-131 (2012).","journal-title":"BMC Infect Dis"},{"key":"1234_CR21","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1007\/s10620-010-1179-4","volume":"55","author":"YF Liaw","year":"2010","unstructured":"Liaw, Y. F., Lau, G. K., Kao, J. H. & Gane, E. Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection. Dig Dis Sci \n                           55, 2727\u20132734, doi:10.1007\/s10620-010-1179-4 (2010).","journal-title":"Dig Dis Sci"},{"key":"1234_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jmv.1890130410","volume":"13","author":"YF Liaw","year":"1984","unstructured":"Liaw, Y. F. et al. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Journal of medical virology \n                           13, 385\u2013391, doi:10.1002\/(ISSN)1096-9071 (1984).","journal-title":"Journal of medical virology"},{"key":"1234_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/jmv.10534","volume":"72","author":"JH Kao","year":"2004","unstructured":"Kao, J. H., Chen, P. J., Lai, M. Y. & Chen, D. S. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. Journal of medical virology \n                           72, 363\u2013369, doi:10.1002\/jmv.10534 (2004).","journal-title":"Journal of medical virology"},{"key":"1234_CR24","doi-asserted-by":"publisher","first-page":"S346","DOI":"10.1111\/j.1440-1746.1997.tb00520.x","volume":"12","author":"YF Liaw","year":"1997","unstructured":"Liaw, Y. F. Current therapeutic trends in therapy for chronic viral hepatitis. J Gastroenterol Hepatol \n                           12, S346\u2013353, doi:10.1111\/j.1440-1746.1997.tb00520.x (1997).","journal-title":"J Gastroenterol Hepatol"},{"key":"1234_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/gast.2003.50053","volume":"124","author":"JH Kao","year":"2003","unstructured":"Kao, J. H., Chen, P. J., Lai, M. Y. & Chen, D. S. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology \n                           124, 327\u2013334, doi:10.1053\/gast.2003.50053 (2003).","journal-title":"Gastroenterology"},{"key":"1234_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/sti.78.3.166","volume":"78","author":"M Kawsar","year":"2002","unstructured":"Kawsar, M. & Goh, B. T. Hepatitis B virus infection among Chinese residents in the United Kingdom. Sex Transm Infect \n                           78, 166\u2013168, doi:10.1136\/sti.78.3.166 (2002).","journal-title":"Sex Transm Infect"},{"key":"1234_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s10654-004-5755-9","volume":"19","author":"F Denis","year":"2004","unstructured":"Denis, F. et al. Screening of pregnant women for hepatitis B markers in a French Provincial University Hospital (Limoges) during 15 years. Eur J Epidemiol \n                           19, 973\u2013978, doi:10.1007\/s10654-004-5755-9 (2004).","journal-title":"Eur J Epidemiol"},{"key":"1234_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1471-2458-8-49","volume":"8","author":"CC Lin","year":"2008","unstructured":"Lin, C. C. et al. Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries. BMC Public Health \n                           8, 49, doi:10.1186\/1471-2458-8-49 (2008).","journal-title":"BMC Public Health"},{"key":"1234_CR29","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.vaccine.2005.11.035","volume":"24","author":"CJ Clements","year":"2006","unstructured":"Clements, C. J. et al. Progress in the control of hepatitis B infection in the Western Pacific Region. Vaccine \n                           24, 1975\u20131982, doi:10.1016\/j.vaccine.2005.11.035 (2006).","journal-title":"Vaccine"},{"key":"1234_CR30","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2471\/BLT.08.059220","volume":"87","author":"M Rani","year":"2009","unstructured":"Rani, M., Yang, B. & Nesbit, R. Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications. Bull World Health Organ \n                           87, 707\u2013713, doi:10.2471\/BLT.00.000000 (2009).","journal-title":"Bull World Health Organ"},{"key":"1234_CR31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/eurpub\/cks067","volume":"23","author":"JJ Chu","year":"2013","unstructured":"Chu, J. J. et al. Changing epidemiology of hepatitis B and migration\u2013a comparison of six Northern and North-Western European countries. Eur J Public Health \n                           23, 642\u2013647, doi:10.1093\/eurpub\/cks067 (2013).","journal-title":"Eur J Public Health"},{"key":"1234_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/jmv.10094","volume":"67","author":"Z Sun","year":"2002","unstructured":"Sun, Z., Ming, L., Zhu, X. & Lu, J. Prevention and control of hepatitis B in China. Journal of medical virology \n                           67, 447\u2013450, doi:10.1002\/jmv.10094 (2002).","journal-title":"Journal of medical virology"},{"key":"1234_CR33","unstructured":"Progress towards measles elimination -South-East Asia Region, 2003\u20132013. Releve epidemiologique hebdomadaire \n                           90, 297\u2013305 (2015)."},{"key":"1234_CR34","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.amjmed.2003.12.040","volume":"116","author":"CM Chu","year":"2004","unstructured":"Chu, C. M., Hung, S. J., Lin, J., Tai, D. I. & Liaw, Y. F. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med \n                           116, 829\u2013834, doi:10.1016\/j.amjmed.2003.12.040 (2004).","journal-title":"Am J Med"},{"key":"1234_CR35","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1111\/j.1365-2893.2011.01535.x","volume":"19","author":"CS Hsu","year":"2012","unstructured":"Hsu, C. S. et al. Impact of hepatitis B virus infection on metabolic profiles and modifying factors. J Viral Hepat \n                           19, e48\u201357, doi:10.1111\/j.1365-2893.2011.01535.x (2012).","journal-title":"J Viral Hepat"},{"key":"1234_CR36","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/sj.ijo.0803204","volume":"30","author":"CF Jan","year":"2006","unstructured":"Jan, C. F. et al. A population-based study investigating the association between metabolic syndrome and hepatitis B\/C infection (Keelung Community-based Integrated Screening study No. 10). Int J Obes (Lond) \n                           30, 794\u2013799, doi:10.1038\/sj.ijo.0803204 (2006).","journal-title":"Int J Obes (Lond)"},{"key":"1234_CR37","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.ijo.0803479","volume":"31","author":"CM Chu","year":"2007","unstructured":"Chu, C. M., Lin, D. Y. & Liaw, Y. F. Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection? Int J Obes (Lond) \n                           31, 871\u2013875, doi:10.1038\/sj.ijo.0803479 (2007).","journal-title":"Int J Obes (Lond)"},{"key":"1234_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ijo.2012.63","volume":"37","author":"CH Chiang","year":"2013","unstructured":"Chiang, C. H. et al. Association between obesity, hypertriglyceridemia and low hepatitis B viral load. Int J Obes (Lond) \n                           37, 410\u2013415, doi:10.1038\/ijo.2012.63 (2013).","journal-title":"Int J Obes (Lond)"},{"key":"1234_CR39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S0016-5085(00)70261-7","volume":"118","author":"JH Kao","year":"2000","unstructured":"Kao, J. H., Chen, P. J., Lai, M. Y. & Chen, D. S. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology \n                           118, 554\u2013559, doi:10.1016\/S0016-5085(00)70261-7 (2000).","journal-title":"Gastroenterology"},{"key":"1234_CR40","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1053\/j.gastro.2004.09.048","volume":"127","author":"YH Ni","year":"2004","unstructured":"Ni, Y. H. et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology \n                           127, 1733\u20131738, doi:10.1053\/j.gastro.2004.09.048 (2004).","journal-title":"Gastroenterology"},{"key":"1234_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/00365520310000500","volume":"38","author":"CM Lee","year":"2003","unstructured":"Lee, C. M. et al. Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan. Scandinavian journal of gastroenterology \n                           38, 95\u2013101, doi:10.1080\/00365520310000500 (2003).","journal-title":"Scandinavian journal of gastroenterology"},{"key":"1234_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin, S. K. et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatology international \n                           10, 1\u201398, doi:10.1007\/s12072-015-9675-4 (2016).","journal-title":"Hepatology international"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01234-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01234-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01234-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T03:54:25Z","timestamp":1671767665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01234-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1234"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01234-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]},"assertion":[{"value":"13 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1212"}}